ICON delivers operational and consulting services to achieve product authorisation, through the strategic design and delivery of real-world evidence studies and late phase research. Our experts help you to identify, generate, synthesise and communicate evidence of treatment value and safety, to help regulators, payers, providers, and patients make informed health decisions.